Skip to main content

New story in Health from Time: Bill Gates on How the U.S. Can Course Correct Its COVID-19 Response: ‘You Wish Experts Were Taking Charge’



The U.S. domestic response to the COVID-19 pandemic thus far has been “weak,” Bill Gates believes. The Bill and Melinda Gates Foundation co-chair and Microsoft co-founder told TIME senior health correspondent Alice Park during a TIME100 Talks discussion on Thursday that he’d give the U.S.’s COVID-19 response, “on a relative and absolute basis, not a passing grade.”

But, he added, the U.S.’s funding for vaccine and therapeutic research “has been the best in the world,” so if it coordinates to share resources globally, the U.S. could “potentially score the highest” in that realm.

During a global pandemic like COVID-19, Gates argued, governments must collaborate to ensure the virus is fully eradicated. The U.S. has historically led global responses to past health crises like smallpox or polio, he told Park, but has been less of a leader during COVID-19. Instead, countries that were exposed to SARS or MERS responded most quickly and “set a very strong model.”

“There’s about six countries that immediately went to the private sector and said okay, ‘how do we get mass testing? We’ll commit to buy tests’,” he said. “That never happened in the U.S.”

Read more: Mapping the Spread of the Coronavirus Outbreak Around the U.S. and the World

The U.S. continues to face huge delays that make many tests “a waste of money,” he continued, adding that while the responsibility for testing has been delegated to the states, they “don’t have enough power” to speed up testing.

“The more you know about this, the more you wish experts were taking charge,” Gates continued.

If the U.S. can get its COVID-19 numbers down in the next few months, he noted, that will make a “huge difference” in terms of the death rate “going into the fall,” which “could be a challenge because people are indoors more, it’s colder and the flu symptoms will be confusing.”

Fall could also bring new developments in vaccine and therapeutic research, however. “Even within two months, we can have some new anti-virals and antibodies that could make a big difference,” Gates said, adding that countries will need to work together to distribute those resources globally.

Companies that create vaccines need to coordinate with those that have factory capacity and adopt tiered pricing “so the poorest countries get it for the lowest price,” he continued. And governments will also need to ensure that the vaccine is allocated equally—not only within countries but between countries. That can’t be done using only market forces, he said. “The private sector all by itself, would simply charge the highest price and only give to the very wealthy.”

As of yet, the U.S. hasn’t “shown up in the international forums where money to get these tools out to countries is being discussed,” he told Park. Still, he continued, “that still absolutely can be fixed.”

Labels:

Popular posts from this blog

New story in Health from Time: Here’s How Quickly Coronavirus Is Spreading in Your State

The novel coronavirus pandemic is a global crisis, a national emergency and a local nightmare. But while a great deal of the focus in the U.S. has been on the federal government’s response, widely criticized as slow and halting , the picture on the ground remains very different in different parts of the country. A TIME analysis of the per capita spread of the epidemic in all 50 states and Washington, D.C. found considerable range in the rate of contagion, and, in some parts of the country, a significant disparity compared to the national figure. The U.S., unlike nations such as South Korea and now Italy , has yet to show signs of bringing the runaway spread of the virus under control. However, while no single state is yet showing strong signs of bending the curve , some are faring much worse than others. The following graphic plots the rise in the total confirmed cases of COVID-19 per 100,000 residents in each state, plotted by the day that each state reported its first case.
Read more

New story in Health from Time: We Need to Take Care of the Growing Number of Long-term COVID-19 Patients

On July 7, 2020, the Boston Red Sox pitcher Eduardo Rodriguez tested positive for the new coronavirus. He was scheduled to start Opening Day for the Sox, but the virus had other plans— damaging Rodriguez’s heart and causing a condition called myocarditis (inflammation of the heart muscle). Now the previously fit 27-year old ace left-hander must sit out the 2020 season to recover. Rodriguez is not alone in having heart damage from SARS-CoV-2, the virus that causes COVID-19. In a new study done in Germany, researchers studied the hearts of 100 patients who had recently recovered from COVID-19. The findings were alarming: 78 patients had heart abnormalities, as shown by a special kind of imaging test that shows the heart’s structure (a cardiac MRI), and 60 had myocarditis. These patients were mostly young and previously healthy . Several had just returned from ski trips. While other studies have shown a lower rate of heart problems—for example, a study of 416 patients hosp
Read more

New story in Health from Time: What We Don’t Know About COVID-19 Can Hurt Us

Countries around the world have introduced stringent control measures to stop COVID-19 outbreaks growing, but now many find themselves facing the same situation again. From Melbourne to Miami, the relaxation of measures had led to increasing flare-ups, which in some places has already meant reclosing schools, businesses or travel routes. Within the U.S. and among different countries , places with wildly varying public-health policies have experienced wildly diverse outcomes. Most ominously, infections are rising rapidly in many places where they once were falling. So how do countries avoid an indefinite, unsustainable, cycle of opening and closing society? What is needed to prevent a future of strict social distancing and closed borders? To escape this limbo, we need to know more about each step in the chain of infection: why some people are more susceptible or have more symptoms, how our interactions and surroundings influence risk, and how we can curb the impact of the re
Read more